More on Hair Follicle Drug Testing <\/strong><\/p>\n\n\n\nWhile unpleasant, drug testing can be an important part of the screening process for employment. Drug abuse can contribute to workplace accidents, which can cost companies thousands of dollars in insurance costs alone. With hair follicle testing, human resources departments can weed out candidates with long-term drug patterns. Individuals who require drug testing for whatever reason can be certain that their hair test results are accurate, so they can meet the demands needed to continue their drug-free life. With nationwide drug-testing clinics offering this method of testing, hair follicle drug testing might be the best option for you or your company. <\/p>\n\n\n\n
Hair follicle testing available from LabCorp includes up to 12 panel hair test: Marijuana, Cocaine, PCP, Opiates \u2013 6AM (Heroin) & Expanded Opiates, Amphetamine w MAMP & MDMA (Ecstasy), Barbiturates, Benzodiazepines, Propoxyphene, Methadone, Oxycodone, Meperidine and Tramadol. <\/p>\n\n\n\n
Hair testing from Quest Diagnostics includes the five panel plus expanded opiates and Oxycodone testing for: Cocaine, Marijuana, PCP, Opiates \u2013 6AM & Expanded Opiates with Oxycodone and Amphetamine w MAMP & MDMA. This includes testing for Ecstasy. <\/p>\n\n\n\n
Contact National Drug Screening for same day service for hair follicle testing in all areas of the United States. Results can take up to seven business days. <\/p>\n","protected":false},"excerpt":{"rendered":"
Hair Follicle Drug Testing Available in all Areas of the United States Whether you are an employer looking to check up on your applicants and employees or an individual who requires periodic, court-ordered drug testing per the terms of your probation, divorce, child custody agreement or other arrangement, hair testing provides a safe, accurate and more humane […]<\/p>\n","protected":false},"author":12,"featured_media":52123,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51391,51535,50870,50862,50935,51365","_relevanssi_noindex_reason":"","footnotes":""},"categories":[50,49],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50983"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=50983"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/50983\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/52123"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=50983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=50983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=50983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}